Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GSK Gains Clarity For Pharma Focus Through Novartis Consumer JV Buy

Mar 27 2018

• By Mandy Jackson

Machinery cogwheels, industry concept

Related Content

Glaxo Set To File Nucala In COPD, Despite Mixed Phase III Results

Sep 13 2017

Trelegy Approval Boosts GSK's US Respiratory Business But Pressure Remains

Sep 19 2017

Novartis in $28.5bn+ mega-deal with GSK, Lilly

Apr 22 2014

GSK Bags Barron As R&D Boss As Vallance Joins UK Government

Nov 08 2017

Walmsley Takes On Oncology: Can GSK Become A Power Player?

Jan 16 2018

Shingrix Seen Replacing Zostavax In EU & US as Shingles Standard Of Care

Jan 31 2018

Gilead's Biktarvy Approval Heightens HIV Competition With ViiV

Feb 07 2018

Walmsley: GSK Is 'Prepared' And 'Ready' For US Advair Generic Launch

Feb 07 2018

GSK Drops Out Of Auction For Pfizer's Consumer Health Unit

Mar 23 2018

GSK Exercises Right To Buy Out Novartis Consumer Healthcare JV For $13bn

Mar 27 2018

Related Companies

GSK plc

Novartis AG

Pfizer Inc.

ViiV Healthcare

Gilead Sciences, Inc.

Genentech, Inc.

Additional Topics

Business Strategies Deals M & A Companies Commercial Consumer BioPharmaceutical

More from Strategy

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window